PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF
    4.
    发明申请
    PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF 有权
    铂化合物,组合物及其用途

    公开(公告)号:US20160317549A1

    公开(公告)日:2016-11-03

    申请号:US15179701

    申请日:2016-06-10

    IPC分类号: A61K31/555

    摘要: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or ligand which may be capable of recognizing a selected target cell population, and/or derivatives/analogs/mimics thereof.

    摘要翻译: 本教导涉及用于治疗癌症的化合物和组合物。 在一些实施方案中,组合物包含具有至少一个反应基团的铂(IV)络合物,所述反应基团可与蛋白质,工程改造的蛋白质,抗体,抗体片段,肽,激动剂,拮抗剂,适体或配体的官能团反应, 识别所选择的靶细胞群体和/或其衍生物/类似物/模拟物。

    Platinum compounds, compositions, and uses thereof
    8.
    发明授权
    Platinum compounds, compositions, and uses thereof 有权
    铂化合物,组合物及其用途

    公开(公告)号:US09403858B2

    公开(公告)日:2016-08-02

    申请号:US14944610

    申请日:2015-11-18

    摘要: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or ligand which may be capable of recognizing a selected target cell population, and/or derivatives/analogs/mimics thereof.

    摘要翻译: 本教导涉及用于治疗癌症的化合物和组合物。 在一些实施方案中,组合物包含具有至少一个反应基团的铂(IV)络合物,所述反应基团可与蛋白质,工程改造的蛋白质,抗体,抗体片段,肽,激动剂,拮抗剂,适体或配体的官能团反应, 识别所选择的靶细胞群体和/或其衍生物/类似物/模拟物。